Medscape

Keeping Current CME

Health EN ↓ 793 episoder

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.

Husk at besøge podcastens hjemmeside og støtte skaberen: keepingcurrentcme.webmd.libsynpro.com

Forfatter

Medscape

Kategori

Health

Podcastens hjemmeside

keepingcurrentcme.webmd.libsynpro.com

Seneste episode

23. okt. 2026

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Installer gratis Android næsten 10 mio. downloads · 4,8 i bedømmelse iOS snart

Episoder

Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at High Risk of Recurrence 18.12.2023 17:53

Your patient has endured surgery, radiation therapy, and chemotherapy. After all that, how do you discuss the risk of recurrence and additional treatment? Credit available for this activity expires: 12/15/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999193?ecd=bdc_podcast_libsyn_mscpedu

Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations 15.12.2023 25:52

How well do you understand the challenges that patients face with hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer with a high risk for recurrence? Credit available for this activity expires: 12/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999101?ecd=bdc_podcast_libsyn_mscpedu

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies 14.12.2023 18:25

Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing? Credit available for this activity expires: 12/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu

Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice 12.12.2023 20:34

Did you know that patients with HER2-low metastatic breast cancer now have approved treatment options? Join for a discussion on trial data and testing. Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999024?ecd=bdc_podcast_libsyn_mscpedu

From Symptom to Solution: Best Practices in Syndromic Testing for Improved Patient Outcomes 11.12.2023 29:41

Do you know how to appropriately incorporate syndromic testing into patient care? Hear from the experts. Credit available for this activity expires: [12/11/24] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999156 ?ecd=bdc_podcast_libsyn_mscpedu

Novel Biologic Therapies for Spondyloarthritis: The Year in Review 08.12.2023 35:19

Are you up to date on latest data on biologics in spondyloarthritis and the recent EULAR treatment recommendation updates? Join us to find out more! Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998991?ecd=bdc_podcast_libsyn_mscpedu

Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors 06.12.2023 28:47

Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL? Credit available for this activity expires: 12/05/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998747?ecd=bdc_podcast_libsyn_mscpedu

Personalizing Risk Assessment to Enhance Primary Cardiovascular Prevention: From Methods to Interpretation 05.12.2023 34:20

Join our experts to hear about imaging strategies to determine cardiovascular (CV) risk and optimum preventive strategies. Credit available for this activity expires: 12/5/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998954?ecd=bdc_podcast_libsyn_mscpedu

Nonalcoholic Steatohepatitis: Mission Possible! 04.12.2023 31:01

Learn to recognize, diagnose, and manage nonalcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH). Credit available for this activity expires: 12/4/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998939?ecd=bdc_podcast_libsyn_mscpedu

Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer 01.12.2023 40:28

View the experts discuss the ins and outs of immunotherapy for advanced non-small cell lung cancer (NSCLC) in the real world. Credit available for this activity expires: 11/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998874?ecd=bdc_podcast_libsyn_mscpedu

ROS1-Positive Advanced NSCLC: Sharing Best Practice From the Clinic to Maximize Patient Outcomes 30.11.2023 31:34

How confident are you in managing patients your patients on ROS1 inhibitor therapy? Credit available for this activity expires: 11/30/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998606?ecd=bdc_podcast_libsyn_mscpedu

What Does It All Mean for Your Practice? Closing Remarks From the Conference Chairs 28.11.2023 27:13

Drs Nelson and Taylor discuss the key takeaways from all the presentations in the Women's Health Master Class. Credit available for this activity expires: 11/28/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998784?ecd=bdc_podcast_libsyn_mscpedu

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist 28.11.2023 28:25

Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)? Credit available for this activity expires: 11/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998529?ecd=bdc_podcast_libsyn_mscpedu

Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit 28.11.2023 1:01:53

How do your treatment decisions compare with the experts? Credit available for this activity expires: 11/28/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998763?ecd=bdc_podcast_libsyn_mscpedu

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate 17.11.2023 32:14

What strategies are you using to individualize treatment of HR+/HER2- early breast cancer? Credit available for this activity expires: 11/17/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998210?ecd=bdc_podcast_libsyn_mscpedu

Communication Strategies With Caregivers Following the Diagnosis of Rett Syndrome 15.11.2023 21:22

How should parents be counseled following a diagnosis of Rett syndrome? Credit available for this activity expires: 11/14/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998424?ecd=bdc_podcast_libsyn_mscpedu

2023 Rett Syndrome Year in Review: Expert Discussion on What's New 15.11.2023 26:13

Are you aware of the latest updates for the treatment of Rett syndrome? Drs Lieberman and Standridge discuss. Credit available for this activity expires: 11/14/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998395?ecd=bdc_podcast_libsyn_mscpedu

Keeping It Current: Latest European Updates in Prostate and Bladder Cancer 10.11.2023 45:08

Drs Agarwal and Grivas delve into the latest data from the European Society for Molecular Oncology (ESMO) 2023 meeting. Credit available for this activity expires: 11/10/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998182?ecd=bdc_podcast_libsyn_mscpedu

Strategies for Improving Patient Outcomes in Pediatric-Onset Seizures 31.10.2023 45:34

Who needs genetic testing, when, what tests, and what next? Credit available for this activity expires: 10/31/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997826?ecd=bdc_podcast_libsyn_mscpedu

Immunotherapy in Special Populations With Non-Small Cell Lung Cancer: What Would the Oncologist Do? 31.10.2023 55:18

Do you know the best way to administer immunotherapy in unique patients with non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 10/27/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997794?ecd=bdc_podcast_libsyn_mscpedu

Navigating the Patient Journey for LA SCCHN: A Look at Treatments for Today and Tomorrow 24.10.2023 55:11

Do you know the best management for your patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)? Credit available for this activity expires: 10/19/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997487?ecd=bdc_podcast_libsyn_mscpedu

Accessible Fertility Care: Breaking the Silence on Infertility 20.10.2023 45:58

How do you engage patients in conception counseling and fertility care? Credit available for this activity expires: 10/20/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997544?ecd=bdc_podcast_libsyn_mscpedu

Biologic Treatment Selection for Psoriatic Disease in a Complex Treatment Landscape 26.09.2023 19:57

Did you know that up to a third of patients with psoriasis go on to develop psoriatic arthritis in the long-term? Credit available for this activity expires: 9/26/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996234?ecd=bdc_podcast_libsyn_mscpedu

Hidden in Plain Sight: Anticholinergic Burden in Patients With Overactive Bladder 26.09.2023 28:06

Did you know that overactive bladder (OAB) affects approximately 35 million people in the United States and negatively impacts psychosocial functioning and quality of life? Credit available for this activity expires: 9/25/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996748?ecd=bdc_podcast_libsyn_mscpedu

Quickfire Updates From Brisbane: Expert Insights on the Latest Data and Implications for HIV Care 31.08.2023 19:20

Are you current on recently presented findings in HIV medicine? Join Drs Rockstroh and Bell for an update. Credit available for this activity expires: 8/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/995914?ecd=bdc_podcast_libsyn_mscpedu